Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus ErythematosusInterventions: Drug: extended release dipyridamole 200mg/aspirin 25mg; Drug: 81mg aspirinSponsors: Oklahoma Medical Research Foundation; Oklahoma Rheumatic Disease Research Cores CenterRecruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 2, 2013 Category: Research Source Type: clinical trials
Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus ErythematosusInterventions: Drug: extended release dipyridamole 200mg/aspirin 25mg; Drug: 81mg aspirinSponsors: Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Oklahoma Rheumatic Disease Research Cores CenterRecruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 2, 2013 Category: Research Source Type: clinical trials
JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme
Condition: Cerebrovascular AccidentInterventions: Drug: Aggrenox capsule; Other: Acetylsalicylic Acid (ASA)Sponsor: Boehringer IngelheimCompleted - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2006 Category: Research Source Type: clinical trials
Treatment of Supine Hypertension in Autonomic Failure
Condition: HypertensionInterventions: Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine; Drug: captopril; Drug: carbidopa; Drug: losartan; Drug: metoprolol tartrate; Drug: nebivolol hydrochloride; Drug: prazosin hydrochloride; Drug: tamsulosin hydrochloride; Other...
Source: ClinicalTrials.gov - September 21, 2005 Category: Research Source Type: clinical trials
Treatment of Supine Hypertension in Autonomic Failure
Condition: HypertensionInterventions: Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine; Drug: captopril; Drug: carbidopa; Drug: losartan; Drug: metoprolol tartrate; Drug: nebivolol hydrochloride; Drug: prazosin hydrochloride; Drug: tamsulosin hydrochloride; Other...
Source: ClinicalTrials.gov - September 14, 2005 Category: Research Source Type: clinical trials
